Publications
Detailed Information
Preoperative [(18)F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Hyun Hoon | - |
dc.contributor.author | Nam, Byung-Ho | - |
dc.contributor.author | Kim, Jae Weon | - |
dc.contributor.author | Kang, Keon Wook | - |
dc.contributor.author | Song, Yong-Sang | - |
dc.contributor.author | Kang, Soon-Beom | - |
dc.contributor.author | Chung, June-Key | - |
dc.contributor.author | Park, Noh-Hyun | - |
dc.date.accessioned | 2012-07-03T08:30:42Z | - |
dc.date.available | 2012-07-03T08:30:42Z | - |
dc.date.issued | 2010-08 | - |
dc.identifier.citation | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING; Vol.37 8; 1467-1473 | ko_KR |
dc.identifier.issn | 1619-7070 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78312 | - |
dc.description.abstract | To determine if preoperative [(18)F]FDG-PET/CT imaging has prognostic significance in patients with uterine cervical cancer. Patients with FIGO stage IB to IIA cervical cancer were imaged with integrated FDG PET/CT before radical surgery. The relationship between the maximum standardized uptake value (SUV(max)) of FDG in the primary tumour during PET/CT and recurrence was examined. Included in the study were 75 patients. Medical records including clinical data, treatment modalities, and treatment results were retrospectively reviewed. The median duration of follow-up was 13 months (range 3 to 58 months) after treatment. Median preoperative SUV(max) values in the primary tumours were significantly higher in patients with higher FIGO stages (p = 0.0149), pelvic lymph node metastasis (p = 0.0068), parametrial involvement (p = 0.0002), large (> 4 cm) tumour size (p = 0.0022), presence of lymphovascular space invasion (p = 0.0055), and deep cervical stromal invasion (p < 0.0001). In univariate analysis, lymph node metastasis, parametrial invasion, presence of lymphovascular space invasion, and preoperative SUV(max) (uncategorized values) in the primary tumour were significantly associated with recurrence. However, in multivariate analysis, preoperative SUV(max) (p = 0.014, HR 1.178, 95% CI 1.034-1.342), age (p = 0.021, HR 0.87, 95% CI 0.772-0.980), and parametrial involvement (p = 0.040, HR 27.974, 95% CI 1.156-677.043) by primary tumour were significantly associated with recurrence. Preoperative FDG uptake by the primary tumour showed a significant association with recurrence in patients with uterine cervical cancer. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | SPRINGER | ko_KR |
dc.subject | FDG PET/CT | ko_KR |
dc.subject | SUV | ko_KR |
dc.subject | Recurrence | ko_KR |
dc.subject | Cervical cancer | ko_KR |
dc.title | Preoperative [(18)F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정현훈 | - |
dc.contributor.AlternativeAuthor | 남병호 | - |
dc.contributor.AlternativeAuthor | 김재원 | - |
dc.contributor.AlternativeAuthor | 강건욱 | - |
dc.contributor.AlternativeAuthor | 박노현 | - |
dc.contributor.AlternativeAuthor | 송용상 | - |
dc.contributor.AlternativeAuthor | 정준기 | - |
dc.contributor.AlternativeAuthor | 강순범 | - |
dc.identifier.doi | 10.1007/s00259-010-1413-5 | - |
dc.citation.journaltitle | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - |
dc.description.citedreference | Lee YY, 2009, GYNECOL ONCOL, V115, P65, DOI 10.1016/j.ygyno.2009.06.022 | - |
dc.description.citedreference | Kim YT, 2009, J GYNECOL ONCOL, V20, P1, DOI 10.3802/jgo.2009.20.1.1 | - |
dc.description.citedreference | Hoang JK, 2008, J CLIN ONCOL, V26, P1459, DOI 10.1200/JCO.2007.14.3628 | - |
dc.description.citedreference | Schwarz JK, 2007, JAMA-J AM MED ASSOC, V298, P2289 | - |
dc.description.citedreference | Horn LC, 2007, GYNECOL ONCOL, V107, P310, DOI 10.1016/j.ygyno.2007.06.026 | - |
dc.description.citedreference | Kidd EA, 2007, CANCER, V110, P1738, DOI 10.1002/cncr.22974 | - |
dc.description.citedreference | Chung HH, 2007, GYNECOL ONCOL, V104, P529, DOI 10.1016/j.ygyno.2006.09.009 | - |
dc.description.citedreference | Chung HH, 2006, GYNECOL ONCOL, V103, P165, DOI 10.1016/j.ygyno.2006.02.016 | - |
dc.description.citedreference | Yen TC, 2006, INT J RADIAT ONCOL, V65, P1307 | - |
dc.description.citedreference | WUE F, 2006, GYNECOL ONCOL, V101, P147, DOI DOI 10.1016/J.YGYNO.2005.10.005 | - |
dc.description.citedreference | Sasaki R, 2005, J CLIN ONCOL, V23, P1136, DOI 10.1200/JCO.2005.06.129 | - |
dc.description.citedreference | Higashi K, 2005, J NUCL MED, V46, P267 | - |
dc.description.citedreference | Schwarzbach MHM, 2005, ANN SURG, V241, P286, DOI 10.1097/01.sla.0000152663.61348.6f | - |
dc.description.citedreference | Downey RJ, 2004, J CLIN ONCOL, V22, P3255, DOI 10.1200/JCO.2004.11.109 | - |
dc.description.citedreference | Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039 | - |
dc.description.citedreference | Grigsby PW, 2004, J CLIN ONCOL, V22, P2167, DOI 10.1200/JCO.2004.09.035 | - |
dc.description.citedreference | Ellenson LH, 2004, CANCER CELL, V5, P533 | - |
dc.description.citedreference | Yen TC, 2004, J NUCL MED, V45, P22 | - |
dc.description.citedreference | Waggoner SE, 2003, LANCET, V361, P2217 | - |
dc.description.citedreference | Allal AS, 2002, J CLIN ONCOL, V20, P1398 | - |
dc.description.citedreference | Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704 | - |
dc.description.citedreference | Grigsby PW, 2001, J CLIN ONCOL, V19, P3745 | - |
dc.description.citedreference | BENEDET JL, 2001, J EPIDEMIOL BIOSTAT, V6, P7 | - |
dc.description.citedreference | Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201 | - |
dc.description.citedreference | Rose PG, 1999, J CLIN ONCOL, V17, P41 | - |
dc.description.citedreference | Landoni F, 1997, LANCET, V350, P535 | - |
dc.description.citedreference | WERNERWASIK M, 1995, INT J RADIAT ONCOL, V32, P1309 | - |
dc.description.citedreference | DELGADO G, 1990, GYNECOL ONCOL, V38, P352 | - |
dc.description.citedreference | BOYCE J, 1981, GYNECOL ONCOL, V12, P154 | - |
dc.description.citedreference | CHUNG CK, 1980, AM J OBSTET GYNECOL, V138, P550 | - |
dc.description.citedreference | VANNAGELL JR, 1978, CANCER, V41, P228 | - |
dc.description.tc | 5 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.